Rilmenidine Phosphate

磷酸利美尼定

Report date: 2022/09/08 13:31:28
NME

Base Information

Drug NameRilmenidine Phosphate
Drug Alias NameTenaxumHyperlexHyperiumHyperdixIterium +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date1988/01/01
Country/TerritoryFranceMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesLes Laboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesLes Laboratoires Servier
Inactive CompaniesLes Laboratoires Servier Beijing Office
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC02AC06
Related LinksWikipediaKEGG